SCHEMBL30457436

SCHEMBL30457436

Clc1ccc(Oc2cccc(Br)c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 5/20 0.47
▸ MAOA P21397 2/20 0.47
▸ ALDH1A1 P00352 3/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ MITF O75030 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ GFER P55789 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ NLRP1 Q9C000 1/20 0.45
▸ NOD2 Q9HC29 1/20 0.45
▸ HPGD P15428 1/20 0.44
▸ PGR P06401 1/20 0.43
▸ PPARG P37231 1/20 0.42
▸ PPARA Q07869 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ EGFR P00533 1/20 0.41
▸ FNTA P49354 1/20 0.40
▸ FNTB P49356 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8388081 1.00 MAOB (0.47) MAOBMAOAALDH1A1SMN1; SMN2MEN1
SCHEMBL3838974 0.89 ALDH1A1 (0.54) MAOBALDH1A1SMN1; SMN2MEN1MITF
SCHEMBL3839157 0.89 ALDH1A1 (0.54) MAOBALDH1A1SMN1; SMN2MEN1MITF
SCHEMBL3838956 0.87 SMN1; SMN2 (0.58) MAOBALDH1A1SMN1; SMN2MEN1MITF
SCHEMBL11815584 0.86 SLC6A4 (0.50) MAOBLMNAEGFR
SCHEMBL30633275 0.85 MAOB (0.55) MAOBMAOAALDH1A1SMN1; SMN2MEN1
SCHEMBL3840708 0.85 MAOB (0.55) MAOBMAOAALDH1A1SMN1; SMN2MEN1
SCHEMBL16890736 0.85 ALDH1A1 (0.60) MAOBMAOAALDH1A1SMN1; SMN2MEN1
SCHEMBL457828 0.85 MAOB (0.54) MAOBALDH1A1SMN1; SMN2MEN1MITF
SCHEMBL30020579 0.83 LTA4H (0.57) MAOBALDH1A1SMN1; SMN2MEN1MITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4447963-A1 SELECTIVE PHD1 INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Akebia Therapeutics Inc. (US) 2024-10-23 — — EP disclosed
CN-118715015-A Selective PHD1 inhibitor compounds, compositions and methods of use 阿克比治疗有限公司 2024-09-27 — — CN disclosed
WO-2023111990-A1 SELECTIVE PHD1 INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USE AKEBIA THERAPEUTICS, INC. (US) 2023-06-22 — — WO disclosed
Send feedback